Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)

China flag China · Delayed Price · Currency is CNY
55.72
+0.58 (1.05%)
At close: Jun 18, 2026
Market Cap5.98B +59.0%
Revenue (ttm)709.72M -0.7%
Net Income-51.39M
EPS-0.47
Shares Out 108.45M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,316,770
Open54.60
Previous Close55.14
Day's Range54.50 - 57.44
52-Week Range41.45 - 77.17
Beta0.37
AnalystsStrong Buy
Price Target83.82 (+50.43%)
Earnings DateAug 14, 2026

About SHE:301096

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. operates as a pharmaceutical technology research and development and services company in China. The company primarily provides drug research and development services; and the transformation of research and development technology results for various pharmaceutical, as well as pharmaceutical research and development investment companies. Its business covers the principal links of drug discovery, pharmaceutical research, clinical trials, customized research and development and production, and registratio... [Read more]

Sector Healthcare
Founded 2011
Employees 1,412
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301096
Full Company Profile

Financial Performance

In 2025, SHE:301096's revenue was 677.99 million, a decrease of -15.45% compared to the previous year's 801.92 million. Losses were -90.40 million, 71.4% more than in 2024.

Financial Statements